Could a simple urine test replace the pap smear for cervical cancer screening?

NCT ID NCT05413798

First seen Jul 01, 2026 · Last updated Jul 02, 2026 · Updated 1 time

Summary

This study investigates whether urine samples can be used to screen for cervical cancer in women living with HIV. Researchers will compare the accuracy of urine HPV testing with self-collected and provider-collected samples to detect cervical precancer (CIN2 or worse). The goal is to find a simpler, less invasive screening method that could be used in low-resource settings.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
Urine HPV testing
What this could lead to
If urine HPV testing proves accurate, it could offer a simpler, less invasive way to screen for cervical cancer, especially in low-resource settings.
What could go wrong
This is a validation study, not a treatment trial. The test may not be as accurate as standard methods, and results may not apply to all populations.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for CERVICAL CANCER are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Clinical HIV Research Unit Temba Lethu Wing Helen Joseph Hospital

    RECRUITING

    Westdene, Johannesburg, 2092, South Africa

More trials for these conditions

Other studies related to the condition(s) this trial covers.